In an unprecedented intervention, Blood Cancer United announced that it has acquired the remaining supply of a promising ...

TuHURA Biosciences, Inc. (NASDAQ: HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel ...

A young Londoner with a rare form of blood cancer has worked with TV soap opera EastEnders to encourage young black women to ...

The alternative text for this image may have been generated using AI. In conclusion, as testing becomes more sensitive and sophisticated, our understanding of targeting MRD in AML is evolving, ...

Acute myeloid leukemia (AML) afflicts older individuals (median age 68 years), the majority of whom are unfit to receive intensive induction chemotherapy. In November 2018, the FDA granted accelerated ...

The pretreatment evaluation of patient-reported, health-related quality of life provides valuable prognostic information on ...

— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients — SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (NASDAQ: OMER) today announced the successful ...

WASHINGTON, Jan. 14, 2026 /PRNewswire/ -- Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment in a new sub-study of its Beat ...

Actress Diane Parish praised for her standout performance as she shares emotional tribute ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...